software program 3d fusion (Siemens Healthineers)
90
Structured Review
Siemens Healthineers
software program 3d fusion
Software Program 3d Fusion, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+program+3d+fusion/3d+postprocessing+software+fusion/pmc04252007-96-17-20
Average 90 stars, based on 1 article reviews
Software Program 3d Fusion, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+program+3d+fusion/3d+postprocessing+software+fusion/pmc04252007-96-17-20
Average 90 stars, based on 1 article reviews
software program 3d fusion - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Positron Emission Tomography:Article Title: Tumour necrosis as assessed with 18 F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements Article Snippet: .. Low-dose CT and 18 F-FDG PET scans were automatically fused by the use of three-dimensional Software:Article Title: Tumour necrosis as assessed with 18 F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements Article Snippet: .. Low-dose CT and 18 F-FDG PET scans were automatically fused by the use of three-dimensional Article Title: Reproducibility of thoracic and abdominal aortic wall measurements with three-dimensional, variable flip angle (SPACE) MRI. Article Snippet: Materials and Methods: Using a T1-weighted threedimensional MRI SPACE sequence, we evaluated the interobserver, intraobserver, and scan–rescan variability of isotropic thoracic and abdominal aortic wall measurements in 15 cardiovascular diseased patients and 6 normal volunteers.. Main outcome analyses were intracorrelation coefficient (ICC), mean relative error (mRE), and sample size calculation at 80% power to be used to compare placebo group and treatment group means in future two-arm randomized clinical trials. Article Title: Readout-segmented multi-shot diffusion-weighted MRI of the knee joint in patients with juvenile idiopathic arthritis Article Snippet: .. DWI b = 800 s/mm 2 ( a ), ADC map ( b ), contrast-enhanced MRI ( c ) and image fusion ( d ) of colorised overlay of DWI signal onto image ( c ) with other:Article Title: Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer Article Snippet: All Article Title: FDOPA PET-CT of Nonenhancing Brain Tumors Article Snippet: Background: Primary brain tumor grading is crucial to rapidly determine the therapeutic impact and prognosis of a brain tumor as well as the tumors’ aggressiveness profile.. On magnetic resonance imaging, high-grade tumors are usually responsible for blood -brain barrier breakdowns, which result in tumor enhancement.. However, this is not always the case. Article Title: Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Article Snippet: Background Small-bowel MRI based on contrast-enhanced T1-weighted sequences has been challenged by diffusionweighted imaging (DWI) for detection of inflammatory bowel lesions and complications in patients with Crohn disease.. Objective To evaluate free-breathing DWI, as compared to contrast-enhanced MRI, in children, adolescents and young adults with Crohn disease.. Materials and methods This retrospective study included 33 children and young adults with Crohn disease ages 17±3 years (mean ± standard deviation) and 27 matched controls who underwent small-bowel MRI with contrast-enhanced T1weighted sequences and DWI at 1.5 T. The detectability of Crohn manifestations was determined. Article Title: Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection. Article Snippet: Background.. – The heterogeneous nature of glioma makes it difficult to select a target for stereotactic biopsy that will be representative of grade severity on non-contrast-enhanced lesion imaging.. The objective of this study was to evaluate the benefit of fusion of metabolic images (PET 18F-DOPA) with magnetic resonance imaging (MRI) morphological images for cerebral biopsy under stereotactic conditions of glioma without contrast enhancement. Magnetic Resonance Imaging:Article Title: Reproducibility of thoracic and abdominal aortic wall measurements with three-dimensional, variable flip angle (SPACE) MRI. Article Snippet: Materials and Methods: Using a T1-weighted threedimensional MRI SPACE sequence, we evaluated the interobserver, intraobserver, and scan–rescan variability of isotropic thoracic and abdominal aortic wall measurements in 15 cardiovascular diseased patients and 6 normal volunteers.. Main outcome analyses were intracorrelation coefficient (ICC), mean relative error (mRE), and sample size calculation at 80% power to be used to compare placebo group and treatment group means in future two-arm randomized clinical trials. Article Title: Readout-segmented multi-shot diffusion-weighted MRI of the knee joint in patients with juvenile idiopathic arthritis Article Snippet: .. DWI b = 800 s/mm 2 ( a ), ADC map ( b ), contrast-enhanced MRI ( c ) and image fusion ( d ) of colorised overlay of DWI signal onto image ( c ) with Generated:Article Title: Reproducibility of thoracic and abdominal aortic wall measurements with three-dimensional, variable flip angle (SPACE) MRI. Article Snippet: Materials and Methods: Using a T1-weighted threedimensional MRI SPACE sequence, we evaluated the interobserver, intraobserver, and scan–rescan variability of isotropic thoracic and abdominal aortic wall measurements in 15 cardiovascular diseased patients and 6 normal volunteers.. Main outcome analyses were intracorrelation coefficient (ICC), mean relative error (mRE), and sample size calculation at 80% power to be used to compare placebo group and treatment group means in future two-arm randomized clinical trials. |